
zzso zzso zzso is commonly used to treat zzso zzso but zzso zzso can be uncomfortable for zzso 

To describe the clinical outcomes using a novel zzso zzso surface zzso zzso zzso technique to treat brain zzso 

Data were zzso gathered for 44 consecutive patients totaling 115 zzso zzso treated with zzso in a median of 1 fraction zzso zzso to a median dose of 20 zzso zzso zzso zzso Local control, regional control, and overall survival were estimated by the zzso zzso 

Median follow-up for all patients was zzso months zzso zzso zzso with 31 of 44 zzso deceased at the time of zzso The 35 patients zzso with follow-up imaging totaled 88 zzso zzso for local zzso zzso 6- and 12-month local control was zzso zzso confidence zzso zzso and zzso zzso confidence zzso zzso zzso Regional failure was observed in 16 patients zzso The median zzso overall survival was zzso months zzso confidence zzso zzso Analysis of the subset of 22 patients (55 zzso who received zzso alone (no prior zzso in a single fraction yielded comparable clinical zzso Grade 3 or greater toxicity occurred in 4 patients zzso The median treatment time from beam on to beam off was 15 minutes zzso zzso zzso 

zzso for treating zzso zzso can produce clinical outcomes comparable to those with conventional zzso and zzso zzso zzso techniques while providing greater patient comfort with an zzso mask and fast treatment zzso 

